ASCEND CSP IDE Study (NCT06830746)
A Stylet-Driven ICD Lead Intended for Conduction System Pacing IDE Study
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective, multi-center, global, single-arm, pivotal investigational study designed to evaluate the safety and effectiveness of the CSP ICD Lead in a subject population indicated for ICD or CRT-D therapy. The clinical investigation will enroll up to 414 subjects at up to 70 participating centers from the United States, Canada, Europe, and Asia Pacific.
Who can join: Review the eligibility criteria below.
Location: Heart Center Research LLC — Huntsville, Alabama
Age range: 18 Years to 99 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (37 Sites)
Showing the first 25 of 37 sites.
- Heart Center Research LLC — Huntsville, Alabama
- Banner University Medical Center Phoenix — Phoenix, Arizona
- Arrhythmia Research Group — Jonesboro, Arkansas
- Premier Cardiology, Inc. — Newport Beach, California
- University of California at San Diego (UCSD) Medical Center — San Diego, California
- MedStar Washington Hospital Center — Washington D.C., District of Columbia
- AdventHealth Orlando — Orlando, Florida
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- New York Presbyterian Hospital/Cornell University — New York, New York
- The Cleveland Clinic Foundation — Cleveland, Ohio
- Geisinger Medical Center — Danville, Pennsylvania
- Lancaster General Hospital — Lancaster, Pennsylvania
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
- Erlanger Medical Center — Chattanooga, Tennessee
- Medical City Dallas Hospital — Dallas, Texas
- Sentara Norfolk General Hospital — Norfolk, Virginia
- The Prince Charles Hospital — Chermside, Queensland
- Princess Alexandra Hospital — Woolloongabba, Queensland
- Royal Adelaide Hospital — Adelaide, South Australia
- Monash Health — Clayton, Victoria
- MUHC- Montreal General Hospital — Montreal,
- CHRU Hopital de Pontchaillou — Rennes, Brittan
- CHU Trousseau — Chambray-lès-Tours, Centre-Val de Loire
- Hôpital Pitié Salpetrière — Paris, Ile
- Prince of Wales Hospital — Hong Kong,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Failure
- REDUCE LAP-HFREF TRIAL — New York, New York
- Physiological Effects Ketone Ester in Heart — Cleveland, Ohio
- DASH Diet in Heart Failure Outpatients — Sacramento, California
- Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Huntsville, Alabama
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Birmingham, Alabama
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Alexander City, Alabama
Explore by condition: All Heart Failure clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.